Transcriptional cross-talk, the second mode of steroid hormone receptor action

Journal of Molecular Medicine

Volumn 76, Issue 7, 1998, Pages 480-489

  Göttlicher, Martin ^a,b   Heck, Stefanie ^a   Herrlich, Peter ^a,c,d  

^a KARLSRUHE INSTITUTE OF TECHNOLOGY   (Germany)

^b STANFORD UNIVERSITY   (United States)

^c MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

^d UNIVERSITY OF KARLSRUHE   (Germany)

Author keywords

Activating protein 1; Gene expression; Immune response; Nuclear factor B; Steroid receptors

Indexed keywords

DNA BINDING PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STEROID HORMONE; STEROID RECEPTOR; TRANSCRIPTION FACTOR AP 1;

GENE EXPRESSION; HORMONE RECEPTOR INTERACTION; HORMONE RESPONSIVE ELEMENT; IMMUNE RESPONSE; ONCOGENE C FOS; ONCOGENE C JUN; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PROTEIN INTERACTION; REVIEW;

ANIMALS; HUMANS; RECEPTORS, STEROID; SIGNAL TRANSDUCTION; STEROIDS; TRANSCRIPTION, GENETIC;

EID: 0031865468     PISSN: 09462716     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001090050242     Document Type: Review

References (124)

1. Beato M, Herrlich P, Schütz G (1995) Steroid hormone receptors: many actors in search of a plot. Cell 83:851-857
2. Kastner P, Mark M, Chambon P (1995) Nonsteroid nuclear receptors: what are genetic studies telling us about their role in real life? Cell 83:859-869
3. Mangelsdorf DJ, Evans RM (1995) The RXR heterodimers and orphan receptors. Cell 83:841-850
4. Mangelsdorf DJ, Thummel C, Beato M, Herrlich P, Schutz G, Umesono K, Blumberg B, Kastner P, Mark M, Chambon P et al (1995) The nuclear receptor superfamily: the second decade. Cell 83:835-839
5. Angel P, Karin M (1991) The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1072:129-157
6. Cano E, Mahadevan LC (1995) Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20:117-122
7. Treisman R (1996) Regulation of transcription by MAP kinase cascades. Curr Op Cell Biol 8:205-215
8. Jonat C, Rahmsdorf HJ, Park KK, Cato AC, Gebel S, Ponta H, Herrlich P (1990) Antitumor promotion and antiinflammation: down-modulation of AP-I (Fos/Jun) activity by glucocorticoid hormone. Cell 62:1189-2104
9. Lucibello FC, Slater EP, Jooss KU, Beato M, Müller R (1990) Mutual transrepression of Fos and the glucocorticoid receptor: involvement of a functional domain in Fos which is absent in FosB. EMBO J 9:2827-2834
10. Schüle R, Rangarajan P, Kliewer S, Ransone LJ, Bolado J, Yang N, Verma IM, Evans RM (1990) Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor. Cell 62:1217-1226
11. Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M (1990) Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 62: 1205-1215
12. Shemshedini L, Knauthe R, Sassone-Corsi P, Pomon A, Gronemeyer H (1991) Cell-specific inhibitory and stimulatory effects of Fos and Jun on transcription activation by nuclear receptors. EMBO J 10:3839-3849
13. Touray M, Ryan F, Jaggi R, Martin F (1991) Characterisation of functional inhibition of the glucocorticoid receptor by Fos/Jun. Oncogene 6:1227-1234
14. Lucas PC, Granner DK (1992) Hormone response domains in gene transcription. Annu Rev Biochem 61:1131-1173
15. Diamond MI, Miner JN, Yoshinaga SK, Yamamoto KR (1990) Transcription factor interactions: selectors of positive or negative regulation from a single DNA element. Science 249:1266-1272
16. Schüle R, Evans RM (1991) Cross-coupling of signal transduction pathways: zinc finger meets leucine zipper. Trends Genet 7: 377-381
17. Jonat C, Stein B, Ponta H, Herrlich P, Rahmsdorf HJ (1992) Positive and negative regulation of collagenase gene expression. Matrix Suppl 1:145-155
18. Lafyatis R, Kim SJ, Angel P, Roberts AB, Sporn MB, Karin M, Wilder RL (1990) Interleukin-1 stimulates and all-trans-retinoic acid inhibits collagenase gene expression through its 5′ activator protein-1-binding site. Mol Endocrinol 4:973-980
19. Nicholson RC, Mader S, Nagpal S, Leid M, Rochette-Egly C, Chambon P (1990) Negative regulation of the rat stromelysin gene promoter by retinoic acid is mediated by an AP1 binding site. EMBO J 9:4443-4454
20. Salbert G, Fanjul A, Piedrafita FJ, Lu XP, Kim SJ, Tran P, Pfahl M (1993) Retinoic acid receptors and retinoid X receptor-alpha down-regulate the transforming growth factor-beta 1 promoter by antagonizing AP-1 activity. Mol Endocrinol 7:1347-1356
21. Bubulya A, Wise SC, Shen XQ, Burmeister LA, Shemshedini L (1996) c-Jun can mediate androgen receptor-induced transactivation. J Biol Chem 271:24583-24589
22. Miner JN, Yamamoto KR (1992) The basic region of AP-1 specifies glucocorticoid receptor activity at a composite response element. Genes Dev 6:2491-2501
23. Heck S, Kullmann M, Gast A, Ponta H, Rahmsdorf HJ, Herrlich P, Cato AC (1994) A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1. EMBO J 13:4087-4095
24. Lefstin JA, Thomas JR, Yamamoto KR (1994) Influence of a steroid receptor DNA-binding domain on transcriptional regulatory functions. Genes Dev 8:2842-2856
25. Kerppola TK, Luk D, Curran T (1993) Fos is a preferential target of glucocorticoid receptor inhibition of AP-1 activity in vitro. Mol Cell Biol 13:3782-3791
26. König H, Ponta H, Rahmsdorf HJ, Herrlich P (1992) Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo. EMBO J 11:2241-2246
27. Reik A, Stewart AF, Schütz G (1994) Cross-talk modulation of signal transduction pathways: two mechanisms are involved in the control of tyrosine aminotransferase gene expression by phorbol esters. Mol Endocrinol 8:490-497
28. Doucas V, Spyrou G, Yaniv M (1991) Unregulated expression of c-Jun or c-Fos proteins but not Jun D inhibits oestrogen receptor activity in human breast cancer derived cells. EMBO J 10:2237-2245
29. Truss M, Beato M (1993) Steroid hormone receptors: interaction with deoxyribonucleic acid and transcription factors. Endocr Rev 14:459-479
30. Chávez S, Candau R, Truss M, Beato M (1995) Constitutive repression and nuclear factor I-dependent hormone activation of the mouse mammary tumor virus promoter in Saccharomyces cerevisiae. Mol Cell Biol 15:6987-6998
31. Li Q, Wrange O (1995) Accessibility of a glucocorticoid response element in a nucleosome depends on its rotational positioning. Mol Cell Biol 15:4375-4384
32. Truss M, Bartsch J, Schelbert A, Hache RJ, Beato M (1995) Hormone induces binding of receptors and transcription factors to a rearranged nucleosome on the MMTV promoter in vivo. EMBO J 14:1737-1751
33. Zhang XK, Dong JM, Chiu JF (1991) Regulation of alpha-fetoprotein gene expression by antagonism between AP-1 and the glucocorticoid receptor at their overlapping binding site. J Biol Chem 266:8248-8254
34. Godowski PJ, Sakai DD, Yamamoto KR (1989) In: Gralla JD (ed) DNA-protein interactions in transcription. UCLA symposia on molecular and cellular biology. Liss, New York, pp 197-210
35. Helmberg A, Auphan N, Caelles C, Karin M (1995) Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 14: 452-460
36. Pearce D, Yamamoto KR (1993) Mineralocorticoid and glucocorticoid receptor activities distinguished by nonreceptor factors at a composite response element. Science 259:1161-1165
37. Starr DB, Matsui W, Thomas JR, Yamamoto KR (1996) Intracellular receptors use a common mechanism to interpret signaling information at response elements. Genes Dev 10:1271-1283
38. Fanjul A, Dawson MI, Hobbs PD, Jong L, Cameron JF, Harlev E, Graupner G, Lu XP, Pfahl M (1994) A new class of retinoids with selective inhibition of AP-1 inhibits proliferation. Nature 372:107-111
39. Chen JY, Penco S, Ostrowski J, Balaguer P, Pons M, Starrett JE, Reczek P, Chambon P, Gronemeyer H (1995) RAR-specific agonist/antagonists which dissociate transactivation and API transrepression inhibit anchorage-independent cell proliferation. EMBO J 14:1187-1197
40. Heck S, Bender K, Kullmann M, Göttlicher M, Herrlich P, Cato ACB (1997) 1κBα-independent downregulation of NF-κB activity by glucocorticoid receptor. EMBO J 16:4698-4707
41. Vayssière BM, Dupont S, Choquart A, Petit F, Garcia T, Marchandeau C, Gronemeyer H, Resche-Rigon M (1997) Synthetic glucocorticoids that dissociate transactivation and AP-1 transrepression exhibit antiinflammatory activity in vivo. Mol Endocrinol 11:1245-1255
42. Barettino D, Vivanco Ruiz MM, Stunnenberg HG (1994) Characterization of the ligand-dependent transactivation domain of thyroid hormone receptor. EMBO J 13:3039-3049
43. Bourguet W, Ruff M, Chambon P, Gronemeyer H, Moras D (1995) Crystal structure of the ligand-binding domain of the human nuclear receptor RXR-alpha. Nature 375:377-382
44. Renaud JP, Rochel N, Ruff M, Vivat V, Chambon P, Gronemeyer H, Moras D (1995) Crystal structure of the RAR-gamma ligand-binding domain bound to all-trans retinoic acid. Nature 378: 681-689
45. Wagner RL, Apriletti JW, McGrath ME, West BL, Baxter JD, Fletterick RJ (1995) A structural role for hormone in the thyroid hormone receptor. Nature 378:690-697
46. Brzozowski AM, Pike ACW, Dauter Z, Hubbard RE, Bonn T, Engström O, Öhman L, Greene GL, Gustafsson J-Å, Carlquist M (1997) Molecular basis of agonism and antagonism in the oestrogen receptor. Nature 389:753-758
47. Göttlicher M, Heck S, Doucas V, Wade E, Kullman M, Cato ACB, Evans RM, Herrlich P (1996) Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor. Steroids 61:257-262
48. Maroder M, Farina AR, Vacca A, Felli MP, Meco D, Screpanti I, Frati L, Gulino A (1993) Cell-specific bifunctional role of Jun oncogene family members on glucocorticoid receptor-dependent transcription. Mol Endocrinol 7:570-584
49. Teurich S, Angel P (1995) The glucocorticoid receptor synergizes with Jun homodimers to activate AP-1-regulated promoters lacking GR binding sites. Chem Senses 20:251-255
50. Perlmann T, Vennström B (1995) The sound of silence. Nature 377:387-388
51. Hörlein AJ, Näär AM, Heinzel T, Torchia J, Gloss B, Kurokawa R, Ryan A, Kamei Y, Söderström M, Glass CK et al (1995) Ligand-independent repression by the thyroid hormone receptor mediated by a nuclear receptor co-repressor. Nature 377:397-404
52. Kurokawa R, Söderström M, Hörlein A, Halachmi S, Brown M, Rosenfeld MG, Glass CK (1995) Polarity-specific activities of retinoic acid receptors determined by a co-repressor. Nature 377:451-454
53. Chen JD, Evans RM (1995) A transcriptional co-repressor that interacts with nuclear hormone receptors. Nature 377:454-457
54. Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH (1993) Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855-859
55. Kwok RP, Lundblad JR, Chrivia JC, Richards JP, Bachinger HP, Brennan RG, Roberts SG, Green MR, Goodman RH (1994) Nuclear protein CBP is a coactivator for the transcription factor CREB. Nature 370:223-226
56. Bannister AJ, Oehler T, Wilhelm D, Angel P, Kouzarides T (1995) Stimulation of c-Jun activity by CBP: c-Jun residues Ser63/73 are required for CBP induced stimulation in vivo and CBP binding in vitro. Oncogene 11:2509-2514
57. Bannister AJ, Kouzarides T (1995) CBP-induced stimulation of c-Fos activity is abrogated by E1 A. EMBO J 14:4758-4762
58. Chakravarti D, LaMorte VJ, Nelson MC, Nakajima T, Schulman IG, Juguilon H, Montminy M, Evans RM (1996) Role of CBP/p300 in nuclear receptor signalling. Nature 383:99-103
59. Haustein B, Eckner R, Di Renzo J, Halachmi S, Liu H, Searcy B, Kurokawa R, Brown M (1996) p300 is a component of an estrosien receptor coactivator complex. Proc Natl Acad Sci U S A 93:11540-11545
60. Kamei Y, Xu L, Heinzel T, Torchia J, Kurokawa R, Gloss B, Lin SC, Heyman RA, Rose DW, Glass CK, Rosenfeld MG (1996) A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414
61. Gill G, Ptashne M (1988) Negative effect of the transcriptional activator GAL4. Nature 334:721-724
62. Bocquel MT, Kumar V, Stricker C, Chambon P, Gronemeyer H (1989) The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor and cell-specific. Nucleic Acids Res 17:2581-2595
63. Meyer ME, Gronemeyer H, Turcotte B, Bocquel MT, Tasset D, Chambon P (1989) Steroid hormone receptors compete for factors that mediate their enhancer function. Cell 57:433-442
64. Bannister AJ, Kouzarides T (1996) The CBP co-activator is a histone acetyltransferase. Nature 384:641-643
65. Yang XJ, Ogryzko VV, Nishikawa J, Howard BH, Nakatani Y (1996) A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1 A. Nature 382:319-324
66. Janknecht R, Hunter T (1996) Transcription. A growing coactivator network. Nature 383:22-23
67. Halachmi S, Marden E, Martin G, MacKay H, Abbondanza C, Brown M (1994) Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription. Science 264: 1455-1458
68. Cavaillès V, Dauvois S, L'Horset F, Lopez G, Hoare S, Kushner PJ, Parker MG (1995) Nuclear factor R1P140 modulates transcriptional activation by the estrogen receptor. EMBO J 14:3741-3751
69. Le Douarin B, Zechel C, Garnier JM, Lutz Y, Tora L, Pierrat P, Heery D, Gronemeyer H, Chambon P, Losson R (1995) The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18. EMBO J 14:2020-2033
70. Oñate SA, Tsai SY, Tsai MJ, O'Malley BW (1995) Sequence and characterization of a coactivator for the steroid hormone receptor superfamily. Science 270:1354-1357
71. Voegel JJ, Heine MJ, Zechel C, Chambon P, Gronemeyer H (1996) TIF2, a 160 kDa transcriptional mediator for the ligand-dependent activation function AF-2 of nuclear receptors. EMBO J 15:3667-3675
72. Yao TP, Ku G, Zhou N, Scully R, Livingston DM (1996) The nuclear hormone receptor coactivator SRC-1 is a specific target of p300. Proc Natl Acad Sci USA 93:10626-10631
73. Cheng X, Reginato MJ, Andrews NC, Lazar MA (1997) The transcriptional integrator CREB-binding protein mediates positive cross talk between nuclear hormone receptors and the hematopoietic bZip protein p45/NF-E2. Mol Cell Biol 17:1407-1416
74. Caldenhoven E, Liden J, Wissink S, Van de Stolpe A, Raaijmakers J, Koenderman L, Okret S, Gustafsson J-Å, Van der Saag PT (1995) Negative cross-talk between RelA and the glucocorticoid receptor: a possible mechanism for the antiinflammatory action of glucocorticoids. Mol Endocrinol 9:401-412
75. Scheinman RI, Gualberto A, Jewell CM, Cidlowski JA, Baldwin AS Jr (1995) Characterization of mechanisms involved in transrepression of NF-kappa B by activated glucocorticoid receptors. Mol Cell Biol 15:943-953
76. Stein B, Yang MX (1995) Repression of the interleukin-6 promoter by estrogen receptor is mediated by NF-kappa B and C/EBP beta. Mol Cell Biol 15:4971-4979
77. Imai E, Miner JN, Mitchell JA, Yamamoto KR, Granner DK (1993) Glucocorticoid receptor-cAMP response element-binding protein interaction and the response of the phosphoenolpyruvate carboxykinase gene to glucocorticoids. J Biol Chem 268: 5353-5356
78. Felli MP, Vacca A, Meco D, Screpanti I, Farina AR, Maroder M, Martinotti S, Petrangeli E, Frati L, Gulino A (1991) Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. Mol Cell Biol 11:4771-4778
79. Kutoh E, Strömstedt PE, Poellinger L (1992) Functional interference between the ubiquitous and constitutive octamer transcription factor 1 (OTF-1) and the glucocorticoid receptor by direct protein-protein interaction involving the homeo subdomain of OTF-1. Mol Cell Biol 12:4960-4969
80. Stein B, Baldwin AS Jr, Ballard DW, Greene WC, Angel P, Herrlich P (1993) Cross-coupling of the NF-kappa B p65 and Fos/Jun transcription factors produces potentiated biological function. EMBO J 12:3879-3891
81. Su H, Bos TJ, Monteclaro FS, Vogt PK (1991) Jun inhibits myogenic differentiation. Oncogene 6:1759-1766
82. Bengal E, Ransone L, Scharfmann R, Dwarki VJ, Tapscot SJ, Weintraub H, Vernia IM (1992) Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell 68:507-519
83. Li L, Chambard J-C, Karin M, Olson E (1992) Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression. Genes Dev 6: 676-689
84. Verma IM, Stevenson JK, Schwarz EM, Van Antwerp D, Miyamoto S (1995) Rel/NF-kappa B/I kappa B family: intimate tales of association and dissociation. Genes Dev 9:2723-2735
85. Baeuerle PA, Baltimore D (1996) NF-kappa B: ten years after. Cell 87:13-20
86. Ito CY, Kazantsev AG, Baldwin AS Jr (1994) Three NF-kappa B sites in the I kappa B-alpha promoter are required for induction of gene expression by TNF alpha. Nucleic Acids Res 22: 3787-3792
87. Auphan N, Di Donato JA, Rosette C, Helmberg A, Karin M (1995) Immunosuppression by glucocorticoids: inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science 270:286-290
88. Scheinman RI, Cogswell PC, Lofquist AK, Baldwin AS Jr (1995) Role of transcriptional activation of I kappa B alpha in mediation of immunosuppression by glucocorticoids. Science 270:283-286
89. Cato AC, Wade E (1996) Molecular mechanisms of anti-inflammatory action of glucocorticoids. Bioessays 18:371-378
90. Adler AJ, Danielsen M, Robins DM (1992) Androgen-specific gene activation via a consensus glucocorticoid response element is determined by interaction with nonreceptor factors. Proc Natl Acad Sci USA 89:11660-11663
91. Claessens F, Alen P, Devos A, Peeters B, Verhoeven G, Rombauts W (1996) The androgen-specific probasin response element 2 interacts differentially with androgen and glucocorticoid receptors. J Biol Chem 271:19013-19016
92. Parrillo JE, Fauci AS (1979) Mechanisms of glucocorticoid action on immune processes. Annu Rev Pharmacol Toxicol 19: 179-201
93. Baeuerle PA, Henkel T (1994) Function and activation of NF-kappa B in the immune system. Annu Rev Immunol 12:141-179
94. van de Stolpe A, Caldenhoven E, Raaijmakers JA, van der Saag PT, Koenderman L (1993) Glucocorticoid-mediated repression of intercellular adhesion molecule-1 expression in human monocytic and bronchial epithelial cell lines. Am J Respir Cell Mol Biol 8:340-347
95. van de Stolpe A, Caldenhoven E, Stade BG, Koenderman L, Raaijmakers JA, Johnson JP, van der Saag PT (1994) 12-O-Tetradecanoylphorbol-13-acetate- and tumor necrosis factor alpha-mediated induction of intercellular adhesion molecule-1 is inhibited by dexamethasone. Functional analysis of the human intercellular adhesion molecular-1 promoter. J Biol Chem 269:6185-6192
96. Frisch SM, Ruley HE (1987) Transcription from the stromelysin promoter is induced by interleukin-1 and repressed by dexamethasone. J Biol Chem 262:16300-16304
97. Arya SK, Wong-Staal F, Gallo RC (1984) Dexamethasone-mediated inhibition of human T cell growth factor and gamma-interferon messenger RNA. J Immunol 133:273-276
98. Serfling E, Barthelmas R, Pfeuffer I, Schenk B, Zarius S, Swoboda R, Mercurio F, Karin M (1989) Ubiquitous and lymphocyte-specific factors are involved in the induction of the mouse interleukin 2 gene in T lymphocytes. EMBO J 8:465-473
99. Jain J, Valge-Archer VE, Rao A (1992) Analysis of the AP-1 sites in the IL-2 promoter. J Immunol 148:1240-1250
100. Northrop JP, Crabtree GR, Mattila PS (1992) Negative regulation of interleukin 2 transcription by the glucocorticoid receptor. J Exp Med 175:1235-1245
101. Vacca A, Felli MP, Farina AR, Martinotti S, Maroder M, Screpanti I, Meco D, Petrangeli E, Frati L, Gulino A (1992) Glucocorticoid receptor-mediated suppression of the interleukin 2 gene expression through impairment of the cooperatively between nuclear factor of activated T cells and AP-1 enhancer elements. J Exp Med 175:637-646
102. Mukaida N, Morita M, Ishikawa Y, Rice N, Okamoto S, Kasahara T, Matsushima K (1994) Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem 269:13289-13295
103. Ray A, Prefontaine KE (1994) Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor. Proc Natl Acad Sci USA 91:752-756
104. Barnes PJ, Adcock I (1993) Anti-inflammatory actions of steroids: molecular mechanisms. Trends Pharmacol Sci 14:436-441
105. Wyllie AH (1980) Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284:555-556
106. Ucker DS (1987) Cytotoxic T lymphocytes and glucocorticoids activate an endogenous suicide process in target cells. Nature 327:62-64
107. Baxter JD, Harris AW, Tomkins GM, Cohn M (1971) Glucocorticoid receptors in lymphoma cells in culture: relationship to glucocorticoid killing activity. Science 171:189-191
108. Gehring U, Tomkins GM (1974) A new mechanism for steroid unresponsiveness: loss of nuclear binding activity of a steroid hormone receptor. Cell 3:301-306
109. Sibley CH, Tomkins GM (1974) Isolation of lymphoma cell variants resistant to killing by glucocorticoids. Cell 2:213-220
110. Sibley CH, Tomkins GM (1974) Mechanisms of steroid resistance. Cell 2:221-227
111. Bourgeois S, Newby RF (1977) Diploid and haploid states of the glucocorticoid receptor gene of mouse lymphoid cell lines. Cell 11:423-430
112. Norman MR, Thompson EB (1977) Characterization of a glucocorticoid-sensitive human lymphoid cell line. Cancer Res 37:3785-3791
113. Bourgeois S, Newby RF, Huet M (1978) Glucorticoid resistance in murine lymphoma and thymoma lines. Cancer Res 38:4279-4284
114. Gillis S, Crabtree GR, Smith KA (1979) Glucocorticoid-induced inhibition of T cell growth factor production. I. The effect on mitogen-induced lymphocyte proliferation. J Immunol 123:1624-1631
115. Gillis S, Crabtree GR, Smith KA (1979) Glucocorticoid-induced inhibition of T cell growth factor production. II. The effect on the in vitro generation of cytolytic T cells. J Immunol 123:1632-1638
116. Cupps TR, Fauci AS (1982) Corticosteroid-mediated immunoregulation in man. Immunol Rev 65:133-155
117. Gasson JC, Bourgeois S (1983) A new determinant of glucocorticoid sensitivity in lymphoid cell lines. J Cell Biol 96:409-415
118. Caron-Leslie LA, Cidlowski JA (1991) Similar actions of glucocorticoids and calcium on the regulation of apoptosis in S49 cells. Mol Endocrinol 5:1169-1179
119. Caron-Leslie LM, Schwartzman RA, Gaido ML, Compton MM, Cidlowski JA (1991) Identification and characterization of glucocorticoid-regulated nuclease(s) in lymphoid cells undergoing apoptosis. J Steroid Biochem Mol Biol 40:661-671
120. Dowd DR, Miesfeld RL (1992) Evidence that glucocorticoid- and cyclic AMP-induced apoptotic pathways in lymphocytes share distal events. Mol Cell Biol 12:3600-3608
121. Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR (1992) Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science 257:212-214
122. Thulasi R, Harbour DV, Thompson EB (1993) Suppression of c-myc is a critical step in glucocorticoid-induced human leukemic cell lysis. J Biol Chem 268:18306-18312
123. Nazareth LV, Harbour DV, Thompson EB (1991) Mapping the human glucocorticoid receptor for leukemic cell death. J Biol Chem 266:12976-12980
124. Dowd DR, MacDonald PN, Komm BS, Haussler MR, Miesfeld R (1991) Evidence for early induction of calmodulin gene expression in lymphocytes undergoing glucocorticoid-mediated apoptosis. J Biol Chem 266:18423-18426